LATEST ARTICLES

Accreditation for Clinical Research Sites Worldwide

As reported in New England Journal of Medicine, standardized accreditation of global clinical research sites will support improved clinical research outcomes world wide.  Nonprofit Alliance...
MS

Study Indicates Stem Cell Relapsing MS Proves Effective and Safe

Northwestern University sponsored a resent stem cell therapy trial involving multiple sclerosis (MS)-- at onset an immune-mediated demyelinating disease. In most cases,...
AI

CRO Charles River Partners with AI Venture Atomwise

Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc. today announced the formation of a strategic alliance that offers clients access...
Leukemia

Pfizer Study Evaluates Addition of Glasdegib in AML & High-Risk MDS Patients

A Pfizer-sponsored study recently generated clinical results. This was a study to evaluate PF-04449913 (an inhibitor of the Hedgehog pathway) in Acute...
Fraud

Fraudulent Venture Attempts to Misappropriate Children’s Hospital of Philadelphia Patents

Children’s Hospital of Philadelphia (CHOP) has sued ViaGenetics, Inc because the firm “uses deceptive means to extract confidential information from scientists and...
Breast Cancer

TRIO Announces First Enrolled Patient into Phase III NATALEE Trial

The NATALEE trial is a Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as...
EU and Canada Health Data

EU & Canada Award 8.4 m. Euros to Bar-Illan University-Led Health Data Project

The Jerusalem Post reports that the EU and the Canadian government have awarded 8.3 million ($9.6 mil) euros to the Israeli—led international...
UK Website HUB

DMD Hub Works to Connect Patients with Clinical Trials Across UK

Emma Yasinski of Muscular Dystrophy News Today reports that Duchenne Muscular Dystrophy (DMD) Hub is building a network of clinical trial sites...
Immune Cancer

Medicine Demonstrates Immunological Effects of Tomivosertib

eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced publication in...
Gout

FDA Seek to Approve Febuxostat for Gout Despite Potential CV Risks

Medscape reports that the FDA’s Arthritis Advisory Committee (AAC) and Drug Safety and Risk Management (DSaRM) Advisory Committee voted by a large...
RA

FRANCIS Trial Results Support Management of CV Risk Favors in RA Patients

Patients with rheumatoid arthritis (RA) have an increased risk for cardiovascular disease (CVD). No long-term intervention trials on CVD risk factors have...